| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.21 | 1e-05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.089 | 0.06 |